+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Liquid Biopsy with Emphasis on Cancer: Global Markets to 2023

  • ID: 4774496
  • Report
  • Region: Global
  • 277 Pages
  • BCC Research
1 of 5

FEATURED COMPANIES

  • Accuragen Inc.
  • Bio-Techne Ltd.
  • Envision Genomics
  • Inivata Ltd.
  • Nugen Technologies Inc.
  • Screencell
  • MORE

Report Scope:

The scope of the report includes liquid biopsy technologies, applications, industry subsegments, biomarker technologies, major funding initiatives, patents and companies. The market sizes for liquid biopsy diagnostics are given for 2017, 2018 and 2023 (forecasted).

This report reviews liquid biopsy biomarkers and technologies and provides background on why a liquid biopsy is increasingly viewed as a replacement for, or a companion to, tissue biopsy. The report discusses several significant, large-scale research initiatives that are contributing to liquid biopsy development. Key forces driving the market are enumerated.

The structures of several important industry subsectors are reviewed, as well as major industry acquisitions and strategic alliances from January 2017 through November 2018. Industry subsectors analyzed include advanced sequencing instruments, droplet digital PCR (polymerase chain reaction), target enrichment, single-cell DNA polymerase, non-invasive prenatal testing (NIPT), fetal-cell NIPT, CTC (circulating tumor cell) capture and detection and liquid biopsy.

The market for liquid biopsy diagnostics is analyzed in depth. The market is analyzed by application (cancer, reproductive health, transplant), biomarker type (nucleic acids, cells, extracellular vesicles, proteins), analysis platform (microarray, NGS, PCR, proteomics and other), analysis purpose (screening/ early detection, diagnosis, therapy guidance, monitoring) and geography (North America, Europe, Asia Pacific, Rest of the World).

Market data covers 2017, 2018 and 2023 (forecasted).

More than 175 companies in the liquid biopsy industry are profiled in this report.

This research provides a summary of the main industry acquisitions and strategic alliances from January 2017 through November 2018, including key alliance trends.

The Report Includes:

  • 27 data tables and 70 additional tables
  • An overview of the global markets for liquid biopsy technologies, applications, industry subsegments
  • Analyses of global market trends with data from 2017 to 2018 and projections of compound annual growth rates (CAGRs) through 2023
  • Regional dynamics of the liquid biopsy diagnostics market covering North America, Europe, APAC and rest of the world covering other emerging economies
  • Discussion of major drivers, current trends and global outlook of liquid biopsy technologies, their growth potential and factors that influence the market
  • Examination of various conventional biopsy methods and highlight how liquid biopsy enabling technologies address the issues and are gaining significant traction with key opinion leaders
  • Comparative study of liquid biopsy with conventional biopsy technologies and coverage of their respective biomarkers
  • Comprehensive company profiles of key market players within the industry, including Apocell Inc., Becton, Dickinson and Co., Clinical Genomics Technologies, Exact Sciences Corp. and Thermo Fisher Scientific Inc.
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Accuragen Inc.
  • Bio-Techne Ltd.
  • Envision Genomics
  • Inivata Ltd.
  • Nugen Technologies Inc.
  • Screencell
  • MORE

Chapter 1 Introduction

  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Scope of Report
  • Information Sources
  • Methodology
  • Geographic Breakdown
  • Analyst's Credentials
  • Custom Research
  • Related Reports

Chapter 2 Summary

Chapter 3 Overview

  • Introduction
  • Liquid Biopsy vs. Traditional Biopsy
  • Markets
  • Forces Driving Growth
  • Key Trends
  • Key Developments in Liquid Biopsy
  • Industry

Chapter 4 Technology Background

  • Liquid Biopsy Biomarkers
  • Cancer Genomics
  • Invasive Prenatal Testing
  • Non-invasive Prenatal Testing (NIPT)
  • Circulating Tumor Cells (CTCs)
  • CTC Workflow
  • Liquid Biopsy vs. Conventional Biopsy
  • Cancer Testing

Chapter 5 Liquid Biopsy Initiatives

  • Immunomonitor Consortium (2018)
  • Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy Program (2018)
  • Liquid Biopsies and Imaging for Improved Cancer Care (2018)
  • Precancer Atlas (2018)
  • TopMed (2017)
  • Blood Profiling Atlas (2016)
  • Human Cell Atlas (2016)
  • Population Sequencing Projects (2016)
  • Cancer-ID (2015)
  • Precision Medicine Initiative (2015)
  • Early Cancer Detection Consortium (2014)
  • CTC Trap Consortium (2012)
  • EpiFemCare (2012)
  • Single-Cell Research (2012)
  • Cambridge Single-Cell Analysis Core Facility
  • Harvard Medical School Single-Cell Core
  • Mayo Medical Genome Facility
  • National Center for Single-Cell Biology
  • Single-Cell Analysis Core
  • UC San Francisco Single-Cell Analysis Center
  • Worldwide Innovative Networking (WIN) Consortium (2010)
  • Next-Generation Single-Cell Analysis Program
  • Single-Cell Proteomics and Lipidomics Project

Chapter 6 Market Breakdown by End User

  • Introduction
  • Cancer Applications
  • Precision Medicine
  • Cancer Biomarker Status
  • Cancer Market Segments
  • NIPT Applications
  • Transplant Diagnostic Applications

Chapter 7 Liquid Biopsy Industry

  • Introduction
  • Advanced Sequencing Instruments Industry
  • NGS Instrument Industry
  • MiSeq
  • NextSeq
  • MiniSeq
  • ISeq 100
  • Ion Torrent
  • PromethIon
  • MinIon
  • GridION X5
  • Third-Generation Sequencing Industry
  • Droplet Digital PCR Industry
  • Target Enrichment and Amplification Industry
  • Single-cell DNA Polymerase Industry
  • Non-Invasive Prenatal Testing Industry
  • Fetal Cell NIPT Industry
  • CTC Capture and Detection Industry
  • Liquid Biopsy Assay Industry

Chapter 8 Industry Acquisitions and Strategic Alliances

  • Mergers and Acquisitions
  • Acquisitions
  • Strategic Alliances
  • Pipeline Analysis
  • Key Trends

Chapter 9 Liquid Biopsy Markets

  • Forces Driving Growth
  • Liquid Biopsy Market by Application
  • Liquid Biopsy Market by Biomarker Type
  • Liquid Biopsy Market by Analysis Platform
  • Liquid Biopsy Market by Analysis Purpose
  • Geographic Markets
  • Non-Invasive Prenatal Testing Market
  • Cancer Markets
  • Cancer Market by Disease Indication
  • Cancer Market by Analysis Purpose
  • Cancer Market by Biomarker Class
  • Cancer Market by Analysis Method
  • Breast Cancer Market
  • Colorectal Cancer Market
  • Hematological Cancer Market
  • Lung Cancer Market
  • Pan-Cancer Market
  • Transplant Markets
  • Regional Market Analysis

Chapter 10 Patent Review/ New Developments

  • Circulating Tumor Cell Patents
  • Exosome Patents
  • Cell-free DNA Patents
  • Liquid Biopsy and Sequencing-Related Patent Issues

Chapter 11 Company Profiles

  • Accuragen Inc.
  • Adaptive Biotechnologies Inc.
  • Advanced Cell Diagnostics Inc.
  • Agilent Technologies, Inc.
  • Akadeum Life Sciences
  • Alcediag
  • Amoy Diagnostics Co. Ltd.
  • Angle Plc
  • Apocell Inc.
  • Apostle Inc.
  • Arcedi Biotech Aps
  • Arup Laboratories
  • Asuragen Inc.
  • Atreca Inc.
  • Aviva Biosciences
  • Baylor Genetics
  • Becton, Dickinson And Co.
  • Bellwether Bio Inc.
  • Berry Genomics Co. Ltd.
  • Bgi Shenzhen
  • Biocartis Nv
  • Biocept Inc.
  • Biocore Co. Ltd.
  • Biodesix Inc.
  • Biofluidica Inc.
  • Biogazelle
  • Biomarx Inc.
  • Bio-Rad Laboratories Inc.
  • Bio-Techne Ltd.
  • Biovendor-Laboratorni Medicina A.S.
  • Bluestar Genomics Inc.
  • Boreal Genomics
  • Cancer Genetics Inc.
  • Caredx Inc.
  • Cegat Gmbh
  • Cellmax Life
  • Cell Microsystems Inc.
  • Celsee Diagnostics
  • Chronix Biomedical
  • Circulogene Theranostics
  • Circulomics Inc.
  • Clinical Genomics Technologies
  • Codiak Biosciences
  • Color Genomics
  • Cs Genetics Ltd.
  • Cygnus Biosciences Co. Ltd.
  • Cynvenio Biosystems Inc.
  • Cytotrack Aps
  • Datar Cancer Genetics Ltd.
  • Diacarta Inc.
  • Diagnologix Llc
  • Diagnomics
  • Direct Genomics Co. Ltd.
  • Dna Electronics Ltd.
  • Dnalytics
  • Dnanexus Inc.
  • Dovetail Genomics Llc
  • Envision Genomics
  • Epic Sciences Inc.
  • Eurofins Scientific
  • Exact Sciences Corp.
  • Exosome Sciences Inc.
  • Expedeon Ag
  • Ezlife Bio Inc.
  • Fabric Genomics
  • Fluxion Biosciences Inc.
  • Freenome Inc.
  • Genapsys Inc.
  • Genedx Inc.
  • Geneseq Biosciences Pty Ltd.
  • Genetics Research Llc
  • Genomatix Gmbh
  • Genomic Health Inc.
  • Genomoncology
  • Genospace
  • Genexosome Technologies Inc.
  • Gigagen Inc.
  • Golden Helix
  • Grail Inc.
  • Guardant Health Inc.
  • Helitec
  • Helix Opco Llc
  • Htg Molecular Diagnostics Inc.
  • Illumina Inc.
  • Immunovia Ab
  • Inex Innovations Exchange Pte. Ltd.
  • Inivata Ltd.
  • Interpace Diagnostics Llc
  • Invitae Inc.
  • Invivoscribe Inc.
  • Jbs Science Inc.
  • Koninklijke Philips N.V.
  • Laboratory Corp. Of America Inc.
  • Lexent Bio Inc.
  • Lucence Diagnostics Pte. Ltd.
  • Mammoth Biosciences Inc.
  • Mdna Life Sciences Inc.
  • Mdxhealth Inc.
  • Medgenome Labs Pvt. Ltd.
  • Medomics Llc
  • Menarini Silicon Biosystems Spa
  • Merck Kgaa
  • Molecular Health Gmbh
  • Myriad Genetics Inc.
  • Namocell Inc.
  • Nanostring Technologies Inc.
  • Nanoview Biosciences Inc.
  • Natera Inc.
  • Naveris Inc.
  • Neogenomics Laboratories
  • New England Biolabs
  • New Oncology Gmbh
  • Nipd Genetics
  • N-Of-One Inc.
  • Novogene Co. Ltd.
  • Nugen Technologies Inc.
  • Nuprobe Inc.
  • Nx Prenatal Inc.
  • Oncocyte Corp.
  • Oncodna S.A.
  • Oxford Nanopore Technologies Ltd.
  • Pacific Biosciences Of California Inc.
  • Pangaea Oncology
  • Paradigm Diagnostics Inc.
  • Parseq Lab Co. Ltd.
  • Pathway Genomics Corp.
  • Personal Genome Diagnostics Inc.
  • Pieriandx
  • Portable Genomics Llc
  • Precipio Inc.
  • Predicine Inc.
  • Premaitha Health Plc
  • Prenetics
  • Provista Diagnostics Inc.
  • Qiagen Nv
  • Quantapore Inc.
  • Quantum Biosystems Inc.
  • Quantumdx
  • Quest Diagnostics Inc.
  • Rarecells Sas
  • Rarecyte Inc.
  • Real Time Genomics Inc.
  • Resolution Bioscience Inc.
  • Roche Holding Ag
  • Screencell
  • Seekin
  • Sengenics Ltd.
  • Sequencing.Com
  • Seven Bridges Genomics Inc.
  • Singlera Genomics Inc.
  • Sophia Genetics
  • Spera Medical
  • Sphere Fluidics Ltd.
  • Stilla Technologies
  • Strand Life Sciences Pvt. Ltd.
  • Stratos Genomics Inc.
  • Syapse
  • Sysmex Inostics Gmbh
  • Tai Diagnostics Inc.
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.
  • Thorne Diagnostics Inc.
  • Transplant Genomics
  • Trovagene Inc.
  • Twinstrand Biosciences
  • Two Pore Guys Inc.
  • Tymora Analytical Operations Llc
  • Ubiquity Genomics Inc.
  • Vortex Biosciences
  • Vela Diagnostics
  • Volitionrx
  • Vortex Biosciences
  • Xing Technologies Llc
  • Yikon Genomics Co. Ltd.

List of Tables
Summary Table: Global Liquid Biopsy Market, by Disease Class, Through 2023
Table 1: Liquid Biopsy Sample Types
Table 2: Liquid Biopsy: Report Scope
Table 3: Global Liquid Biopsy Market, by Analysis Type, Through 2023
Table 4: Forces Driving Growth
Table 5: Key Trends in the Liquid Biopsy Market
Table 6: Liquid Biopsy Industry Subsectors
Table 7: Liquid Biopsy: Biomarker Classes
Table 8: Clinical Implications of CTCs
Table 9: Key Applications of Circulating Tumor DNA (ctDNA)
Table 10: Applications of ctDNA, CTCs and Exosomes
Table 11: Single-Cell Analysis to Identify Cancer Driver Mutations
Table 12: Genomics-Based Oncology Workflow
Table 13: Prenatal Invasive Testing Technologies
Table 14: Invasive and Non-Invasive Prenatal Technologies
Table 15: Unique Challenges: CTC Capture and Analysis
Table 16: CTC Workflow
Table 17: Cell Differentiators
Table 18: Cell Isolation Technologies
Table 19: CTC-Isolating Markers
Table 20: CTC Sample Preparation Technologies
Table 21: Single-Cell Analysis Technologies
Table 22: Limitations of Conventional Biopsy
Table 23: Liquid vs. Traditional Biopsy
Table 24: Estimated Annual Solid Biopsy Procedures in the U.S.: Selected Cancers
Table 25: Main Risks: Needle-Based Tissue Biopsies
Table 26: Factors in Tissue Biopsy
Table 27: Liquid Biopsy Research and Development Programs, 2010-2018
Table 28: Single-Cell Core Research Facilities
Table 29: Source of Foreign Biomarkers for Liquid Biopsy Applications
Table 30: Personalized Medicine for Common Cancer Genetic Mutations
Table 31: Clinical Status of Cancer Biomarkers in Liquid Biopsy
Table 32: Cancer Liquid Biopsy Market Segments
Table 33: Reproductive Health Screening Applications
Table 34: Ethical Issues Associated with NIPT
Table 35: Transplant Diagnostic Applications
Table 36: Key Segments and Trends: Liquid Biopsy Industry
Table 37: Advanced Sequencing Industry Company Positioning
Table 38: End-to-End Sequencing Approaches
Table 39: Next-Generation Sequencing Instrument Companies
Table 40: NGS Instruments
Table 41: Benchtop and Handheld Sequencer Platforms
Table 42: 3GS Industry, by Tier Status
Table 43: Advantages of Droplet Digital PCR for Single-Cell Analysis
Table 44: Digital PCR Liquid Biopsy Industry
Table 45: Target Enrichment Industry
Table 46: Single-Cell DNA Polymerase Industry
Table 47: Major Companies Associated with the NIPT Industry
Table 48: Estimated Number of NIPT Assays, by Company, 2018
Table 49: Germany NGS-Based Non-Invasive Prenatal Diagnostic Companies, 2017
Table 50: NIPT Test Licensing, by Country
Table 51: Fetal Cell NIPT Industry
Table 52: CTC Separations Industry
Table 53: Liquid Biopsy Assay Industry: Company Focus
Table 54: NGS-Based Liquid Biopsy Market Differentiation
Table 55: Liquid Biopsy Industry: Mergers and Acquisitions of Key Players, 2016-2018
Table 56: Liquid Biopsy: Industry Acquisitions, January 2017 Through November 2018
Table 57: Liquid Biopsy: Strategic Alliances, January 2017 Through November 2018
Table 58: Liquid Biopsy: Pipeline Analysis, January 2017 Through December 2018
Table 59: Liquid Biopsy: Forces Driving Growth and Implications Through 2023
Table 60: Global Liquid Biopsy Market, by Application, Through 2023
Table 61: Global Liquid Biopsy Market, by Biomarker Type, Through 2023
Table 62: FDA-Approved or CE-Marked Tests with Epigenetic Component
Table 63: Global Liquid Biopsy Market, by Analysis Platform, Through 2023
Table 64: Global Liquid Biopsy Market, by Analysis Purpose, Through 2023
Table 65: Global Liquid Biopsy Market, by Region, Through 2023
Table 66: Global Market for Liquid Biopsy in NIPT Applications, by Analysis Purpose, Through 2023
Table 67: Global Market for Liquid Biopsy in NIPT Applications, by Risk Type, Through 2023
Table 68: Global Market for Liquid Biopsy in NIPT Applications, by Biomarker Class, Through 2023
Table 69: Global Market for Liquid Biopsy in NIPT Applications, by Analysis Method, Through 2023
Table 70: Limitations of Solid/Tissue Biopsy in Cancer Applications
Table 71: Low-Frequency Mutation Detection
Table 72: Global Market for Liquid Biopsy in Cancer Applications, by Disease Indication, Through 2023
Table 73: Five-Year Survival Rate for Ovarian Cancer
Table 74: NIH Liquid Biopsy Early Detection Initiative
Table 75: Molecular Thyroid Nodule Classifier Tests
Table 76: Global Market for Liquid Biopsy in Cancer Applications, by Analysis Purpose, Through 2023
Table 77: MRI and Liquid Biopsy Methods
Table 78: Early Detection Tissue of Origin Approaches
Table 79: Global Market for Liquid Biopsy in Cancer Applications, by Biomarker Class, Through 2023
Table 80: Global Market for Liquid Biopsy in Cancer Applications, by Analysis Method, Through 2023
Table 81: Global Market for Liquid Biopsy in Breast Cancer Applications, by Analysis Method, Through 2023
Table 82: Global Market for Liquid Biopsy in Colorectal Cancer Applications, by Analysis Method, Through 2023
Table 83: Global Market for Liquid Biopsy in Hematological Cancer Applications, by Analysis Method, Through 2023
Table 84: Global Market for Liquid Biopsy in Lung Cancer Applications, by Analysis Method, Through 2023
Table 85: Global Market for Liquid Biopsy in Pan-Cancer Applications, by Analysis Method, Through 2023
Table 86: Global Market for Liquid Biopsy in Transplant Applications, by Analysis Purpose, Through 2023
Table 87: Global Market for Liquid Biopsy in Transplant Applications, by Organ Type, Through 2023
Table 88: Transplant Procedures Performed in the United States, 2016 Through September 2018
Table 89: Global Market for Liquid Biopsy in Transplant Applications, by Analysis Method, Through 2023
Table 90: Global Market for Liquid Biopsy in Transplant Applications, by Biomarker Class, Through 2023
Table 91: Global Market for Liquid Biopsy in Cancer Applications, by Region, Through 2023
Table 92: Global Market for Liquid Biopsy in NIPT Applications, by Region, Through 2023
Table 93: Global Market for Liquid Biopsy in Transplant Application, by Region, Through 2023
Table 94: Patent Activity for Circulating Tumor Cells (CTCs), by Country/Region, 2008-2018
Table 95: Patent Activity for Exosomes, by Country/Region, 2008-2018
Table 96: Patent Activity for Cell-Free DNA (cfDNA) by Country/Region, 2008-2018
Table 97: Liquid Biopsy and Sequencing-Related Patent Disputes

List of Figures
Summary Figure: Global Liquid Biopsy Market, by Disease Class, 2017-2023
Figure 1: Timeline of Liquid Biopsy Development
Figure 2: Molecular Applications of Biomarkers as Liquid Biopsy for Personalized Medicine
Figure 3: How Cancer Genomics Drive Liquid Biopsy
Figure 4: Clinical Applications of Liquid Biopsy for Precision Medicine
Figure 5: Shedding of Circulating Tumor Cells

Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • Accuragen Inc.
  • Bio-Techne Ltd.
  • Envision Genomics
  • Inivata Ltd.
  • Nugen Technologies Inc.
  • Screencell
  • MORE

Liquid biopsy is an attractive option as a supplement or alternative to tissue biopsy for applications in reproductive health, cancer and transplant medicine. Liquid biopsy involves detecting and analyzing foreign-derived biomarkers present in body fluids such as blood or urine. The origin of the biomarker defines the liquid biopsy application: tumor (cancer applications), fetus (prenatal screening applications) or transplanted organ (transplant medicine applications).

Biomarker types of interest include cell-free DNA (cfDNA), circulating tumor cells (CTCs) and exosomes. Ongoing advances in sensitive molecular technologies such as next-generation DNA sequencing (NGS) and digital polymerase chain reaction (dPCR) enable detection of biomarkers that are present in fluids at very low concentrations.

Competitors clusters around each of the three applications segments: non-invasive prenatal testing (NIPT), cancer and transplant medicine. Although there is recent movement across the segments by some companies.

When compared with a conventional tissue biopsy, liquid biopsy tests address a significant medical need: a biopsy that is non-invasive and has little or no risk of medical complications. The validation of this testing platform and demonstration of clinical utility first occurred in the high-risk pregnancy segment of the NIPT industry, resulting in high market penetration. Substantial progress is being made in the average-risk pregnancy NIPT market segment and in some applications in cancer and transplant medicine.

Reasons for Doing This Study

Conventional biopsy methods are often invasive, uncomfortable and carry risks of side effects. Liquid biopsy addresses these issues because it is non-invasive and carries little, if any, risks of side effects. In the age of genomics and personalized medicine, it is critical for clinicians to have diagnostic tools that can be used on a regular basis to screen, monitor, conduct surveillance, guide treatment or otherwise give valuable genomic information about a disease. Liquid biopsy provides this capability and is of high interest to the medical community.

Liquid biopsy-enabling technologies are coming to the forefront and provide significant market growth momentum to the industry. Downstream analysis technologies such as next-generation sequencing (NGS) and digital PCR are progressing in capabilities, efficiency and costs. Upstream technologies such as microfluidics, cell-free DNA capture and isolation, cell capture and DNA amplification are also making significant progress.

Liquid biopsy is also gaining significant traction with key opinion leaders, medical societies and insurance payors.

As a result, liquid biopsy is penetrating into attractive clinical applications including average-risk, noninvasive prenatal testing and cancer therapy guidance and monitoring. Based on these trends, liquid biopsy markets are emerging rapidly and the need for industry and market characterization is great. The outstanding growth potential for liquid biopsy diagnostics makes it particularly timely for preparing this updated report.

Note: Product cover images may vary from those shown
5 of 5
  • Accuragen Inc.
  • Adaptive Biotechnologies Inc.
  • Advanced Cell Diagnostics Inc.
  • Agilent Technologies, Inc.
  • Akadeum Life Sciences
  • Alcediag
  • Amoy Diagnostics Co. Ltd.
  • Angle Plc
  • Apocell Inc.
  • Apostle Inc.
  • Arcedi Biotech Aps
  • Arup Laboratories
  • Asuragen Inc.
  • Atreca Inc.
  • Aviva Biosciences
  • Baylor Genetics
  • Becton, Dickinson And Co.
  • Bellwether Bio Inc.
  • Berry Genomics Co. Ltd.
  • Bgi Shenzhen
  • Bio-Rad Laboratories Inc.
  • Bio-Techne Ltd.
  • Biocartis Nv
  • Biocept Inc.
  • Biocore Co. Ltd.
  • Biodesix Inc.
  • Biofluidica Inc.
  • Biogazelle
  • Biomarx Inc.
  • Biovendor-Laboratorni Medicina A.S.
  • Bluestar Genomics Inc.
  • Boreal Genomics
  • Cancer Genetics Inc.
  • Caredx Inc.
  • Cegat Gmbh
  • Cell Microsystems Inc.
  • Cellmax Life
  • Celsee Diagnostics
  • Chronix Biomedical
  • Circulogene Theranostics
  • Circulomics Inc.
  • Clinical Genomics Technologies
  • Codiak Biosciences
  • Color Genomics
  • CS Genetics Ltd.
  • Cygnus Biosciences Co. Ltd.
  • Cynvenio Biosystems Inc.
  • Cytotrack Aps
  • Datar Cancer Genetics Ltd.
  • Diacarta Inc.
  • Diagnologix Llc
  • Diagnomics
  • Direct Genomics Co. Ltd.
  • DNA Electronics Ltd.
  • Dnalytics
  • Dnanexus Inc.
  • Dovetail Genomics Llc
  • Envision Genomics
  • Epic Sciences Inc.
  • Eurofins Scientific
  • Exact Sciences Corp.
  • Exosome Sciences Inc.
  • Expedeon Ag
  • Ezlife Bio Inc.
  • Fabric Genomics
  • Fluxion Biosciences Inc.
  • Freenome Inc.
  • Genapsys Inc.
  • Genedx Inc.
  • Geneseq Biosciences Pty Ltd.
  • Genetics Research Llc
  • Genexosome Technologies Inc.
  • Genomatix Gmbh
  • Genomic Health Inc.
  • Genomoncology
  • Genospace
  • Gigagen Inc.
  • Golden Helix
  • Grail Inc.
  • Guardant Health Inc.
  • Helitec
  • Helix Opco Llc
  • HTG Molecular Diagnostics Inc.
  • Illumina Inc.
  • Immunovia Ab
  • Inex Innovations Exchange Pte. Ltd.
  • Inivata Ltd.
  • Interpace Diagnostics Llc
  • Invitae Inc.
  • Invivoscribe Inc.
  • Jbs Science Inc.
  • Koninklijke Philips N.V.
  • Laboratory Corp. Of America Inc.
  • Lexent Bio Inc.
  • Lucence Diagnostics Pte. Ltd.
  • Mammoth Biosciences Inc.
  • Mdna Life Sciences Inc.
  • Mdxhealth Inc.
  • Medgenome Labs Pvt. Ltd.
  • Medomics Llc
  • Menarini Silicon Biosystems Spa
  • Merck Kgaa
  • Molecular Health Gmbh
  • Myriad Genetics Inc.
  • N-Of-One Inc.
  • Namocell Inc.
  • Nanostring Technologies Inc.
  • Nanoview Biosciences Inc.
  • Natera Inc.
  • Naveris Inc.
  • Neogenomics Laboratories
  • New England Biolabs
  • New Oncology Gmbh
  • Nipd Genetics
  • Novogene Co. Ltd.
  • Nugen Technologies Inc.
  • Nuprobe Inc.
  • Nx Prenatal Inc.
  • Oncocyte Corp.
  • Oncodna S.A.
  • Oxford Nanopore Technologies Ltd.
  • Pacific Biosciences Of California Inc.
  • Pangaea Oncology
  • Paradigm Diagnostics Inc.
  • Parseq Lab Co. Ltd.
  • Pathway Genomics Corp.
  • Personal Genome Diagnostics Inc.
  • Pieriandx
  • Portable Genomics Llc
  • Precipio Inc.
  • Predicine Inc.
  • Premaitha Health Plc
  • Prenetics
  • Provista Diagnostics Inc.
  • Qiagen Nv
  • Quantapore Inc.
  • Quantum Biosystems Inc.
  • Quantumdx
  • Quest Diagnostics Inc.
  • Rarecells Sas
  • Rarecyte Inc.
  • Real Time Genomics Inc.
  • Resolution Bioscience Inc.
  • Roche Holding Ag
  • Screencell
  • Seekin
  • Sengenics Ltd.
  • Sequencing.Com
  • Seven Bridges Genomics Inc.
  • Singlera Genomics Inc.
  • Sophia Genetics
  • Spera Medical
  • Sphere Fluidics Ltd.
  • Stilla Technologies
  • Strand Life Sciences Pvt. Ltd.
  • Stratos Genomics Inc.
  • Syapse
  • Sysmex Inostics Gmbh
  • TAI Diagnostics Inc.
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.
  • Thorne Diagnostics Inc.
  • Transplant Genomics
  • Trovagene Inc.
  • Twinstrand Biosciences
  • Two Pore Guys Inc.
  • Tymora Analytical Operations Llc
  • Ubiquity Genomics Inc.
  • Vela Diagnostics
  • Volitionrx
  • Vortex Biosciences
  • Xing Technologies Llc
  • Yikon Genomics Co. Ltd.
Note: Product cover images may vary from those shown
Adroll
adroll